311
Views
10
CrossRef citations to date
0
Altmetric
Review

Metabolic and nutritional changes after bariatric surgery

, &
Pages 217-223 | Published online: 10 Jan 2014

References

  • Mokdad AH, Ford ES, Bowman BA et al.. Diabetes trends in the U.S.: 1990–1998. Diabetes Care23, 1278–1283 (2000).
  • Demaria EJ, Jamal MK. Surgical options for obesity. Gastroenterol. Clin. North Am.34, 127–142 (2005).
  • US Preventive Services Task Force. Guide to Clinical Preventive Services (Second Edition). International Medical Publishing, VA, USA, 219–229 (1996).
  • Roe DA, Eickwort KR. Relationships between obesity and associated health factors with unemployment among low income women. J. Am. Med. Womens Assoc.31, 193–194, 198–199, 203–204 (1976).
  • Mokdad AH, Marks JS, Stroup DF et al. Actual causes of death in the United States, 2000. JAMA29(10), 1263–1264 (2004).
  • Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann. Surg.222, 339–352 (1995).
  • Schauer PR, Burguera B, Ikramuddin S et al. Effect of laparoscopic Roux-En-Y gastric bypass on type 2 diabetes mellitus. Ann. Surg.238, 467–485 (2003).
  • Cowan GSM, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J. Surg.22, 987–992 (1998).
  • Chapman AE, Kiroff G, Game P et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery135, 326–351 (2004).
  • Anonymous. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann. Int. Med.115(12), 956–961 (1991).
  • Scopinaro N, Adami GF, Marinari GM et al. Biliopancreatic diversion. World J. Surg.22, 936–946 (1998).
  • Requarth JA, Burchard KW, Colacchio TA et al. Long-term morbidity following jejunoileal bypass. Arch. Surg.130, 318–325 (1995).
  • Marceau P, Hould FS, Simard S et al. Biliopancreatic diversion with duodenal switch. World J. Surg.22, 947–954 (1998).
  • Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes. Surg.8, 267–282 (1998).
  • Holloway JA, Forney GA, Gould DE. The Lap-Band is an effective tool for weight loss even in the United States. Am. J. Surg.188, 659–662 (2004).
  • O’Brien PE, Dixon JB, Brown W et al. The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes. Surg.12, 652–660 (2002).
  • Scopinaro N, Gianetta E, Adami GF et al. Biliopancreatic diversion for obesity at eighteen years. Surgery119, 261–268 (1996).
  • Hould FS, Lagace M, Marceau P et al. Hastened gastric emptying after parietal gastrectomy and duodenal switch. Obes. Surg.6, 121 (1996).
  • Newbury L, Dolan K, Hatzifotis M et al. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes. Surg.13, 893–895 (2003).
  • Spits Y, De Laey JJ, Leroy BP. Rapid recovery of night blindness due to obesity surgery after vitamin A repletion therapy. Br. J. Ophthalmol.88, 583–585 (2004).
  • Grimm IS, Schindler S, Haluszka O. Steatohepatitis and fatal hepatic failure after biliopancreatic diversion. Am. J. Gastroenterol.87, 775–779 (1992).
  • Mason EE, Ito C. Gastric bypass in obesity. Surg. Clin. North Am.6, 1345–1351 (1967).
  • Griffen WO, Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann. Surg.18 6, 500–509 (1977).
  • Cummings DE, Weigle DS, Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med.346, 1623–1630 (2002).
  • Gasteyger C, Suter M, Gaillard RC, Giusti V. Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am. J. Clin. Nutr.87(5), 1128–1133 (2008).
  • Meyer JH. Nutritional outcomes of gastric operations. Gastroenterol. Clin. North Am.23, 227–260 (1994).
  • Brolin RE. Gastric bypass. Surg. Clin. North Am.81, 1077–1095 (2001).
  • Crowley LV, Seay J, Mullin G. Late effects of gastric bypass for obesity. Am. J. Gastroenterol.11, 850–860 (1984).
  • Suzuki Y, Ishibashi Y, Omura N et al. Alendronate improves vitamin D-resistant osteopenia triggered by gastrectomy in patients with gastric cancer followed long term. J. Gastrointest. Surg.9, 955–960 (2005).
  • Behrns KE, Smith CD, Sarr MG. Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig. Dis. Sci.39, 315–320 (1994).
  • Carvajal SH, Mulvihill SJ. Postgastrectomy syndrome: dumping and diarrhea. Gastroenterol. Clin. North Am.23, 261–279 (1994).
  • Balsiger BM, Poggio JL, Mai J et al. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J. Gastrointest. Surg.4, 598–605 (2000).
  • Sugerman HJ, Londrey GL, Kellum JM et al. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am. J. Surg.157, 93–102 (1989).
  • Howard L, Malone M, Michalek A, Carter J, Alger S, Van Woert J. Gastric bypass and vertical banded gastroplasty – a prospective randomized comparison and 5-year follow-up. Obes. Surg.5, 55–60 (1995).
  • Olbers T, Fagevik-Olsen M, Maleckas A, Lonroth H. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty for obesity. Br. J. Surg.92, 557–562 (2005).
  • Schneider BE, Mun EC. Surgical management of morbid obesity. Diabetes Care28, 475–480 (2005).
  • Howard L, Malone M, Michalek A et al. gastric bypass and vertical banded gastroplasty – a prospective randomized comparison and 5-year follow-up. Obes. Surg.5, 55–60 (1995).
  • Capella JF, Capella RF. The weight reduction operation of choice: vertical banded gastroplasty or gastric bypass? Am. J. Surg.171, 74–79 (1996).
  • Forsell P, Hallberg D, Hellers G. Gastric banding for morbid obesity: initial experience with a new adjustable band. Obes. Surg.3, 369–374 (1993).
  • Belachew M, Legrand M, Vincent V, Lismonde M, Le Docte N, Deschamps V. Laparoscopic adjustable gastric banding. World J. Surg.22, 955–963 (1998).
  • Ren CJ, Horgan S, Ponce J. US experience with the LAP-BAND system. Am. J. Surg.184, 46S–50S (2002).
  • Baltasar A, Bou R, Arlandis F et al. Vertical banded gastroplasty at more than 5 years. Obes. Surg.8, 29–34 (1998).
  • Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann. Surg.205, 613–624 (1987).
  • Favretti F, Cadiere GB, Segato G et al. Laparoscopic banding: selection and technique in 830 patients. Obes. Surg.12, 385–390 (2002).
  • Felberbauer FX, Langer F, Shakeri-Manesch S et al. Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: intermediate-term results from a large series in three Austrian centers. Obes. Surg.18, 814 (2008).
  • Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes. Surg.15, 1469 (2005).
  • Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes. Surg.13, 861 (2003).
  • Parikh M, Ayoung-Chee P, Romanos E et al. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J. Am. Coll. Surg.205(5), 631–635 (2007).
  • Eisenberg D, Bell RL. The impact of bariatric surgery on severely obese patients with diabetes. Diabetes Spectrum16, 240–245 (2003).
  • Pories WJ, Albrecht RJ. Etiology of Type 2 diabetes mellitus: role of the foregut. World J. Surg.25, 527–531 (2001).
  • Creutzfeldt W. The entero-insular axis in Type 2 diabetes-incretins as therapeutic agents. Exp. Clin. Endocrinol. Diabetes109, S288–S303 (2001).
  • Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. Normalization of fasting hyperglycaemia by exogenous glucagons-like peptide 1 (7–36 amide) in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia3 6, 741–744 (1993).
  • Sjostrom CD, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes. Res.7, 477–484 (1999).
  • Sjostrom CD, Peltonen M, Wedel H, Sjostrom L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension36, 20–25 (2000).
  • Foley EF, Benotti PN, Borlase BC, Hollingshead J, Blackburn GL. Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am. J. Surg.163, 294–297 (1992).
  • Maggard MA, Shugarman LR, Suttorp M et al. Meta-analysis: surgical treatment of obesity. Ann. Intern. Med.14 2, 547–559 (2005).
  • Lynch RJ, Eisenberg D, Bell RL. Metabolic consequences of bariatric surgery. J. Clin. Gastroenterol.40(8), 659–668 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.